CHST14
Carbohydrate sulfotransferase 14
Also known as: CHSTE_HUMAN, D4ST-1, D4ST1, HD4ST
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NCH0
- Gene
- CHST14
- Ensembl
- ENSG00000169105
- Chromosome
- 15
- Canonical length
- 376 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the HNK-1 family of sulfotransferases. The encoded protein transfers sulfate to the C-4 hydroxyl of N-acetylgalactosamine residues in dermatan sulfate. Mutations in this gene have been associated with adducted thumb-clubfoot syndrome.[provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>Q8NCH0|CHST14
1 MFPRPLTPLA APNGAEPLGR ALRRAPLGRA RAGLGGPPLL LPSMLMFAVI VASSGLLLMI
61 ERGILAEMKP LPLHPPGREG TAWRGKAPKP GGLSLRAGDA DLQVRQDVRN RTLRAVCGQP
121 GMPRDPWDLP VGQRRTLLRH ILVSDRYRFL YCYVPKVACS NWKRVMKVLA GVLDSVDVRL
181 KMDHRSDLVF LADLRPEEIR YRLQHYFKFL FVREPLERLL SAYRNKFGEI REYQQRYGAE
241 IVRRYRAGAG PSPAGDDVTF PEFLRYLVDE DPERMNEHWM PVYHLCQPCA VHYDFVGSYE
301 RLEADANQVL EWVRAPPHVR FPARQAWYRP ASPESLHYHL CSAPRALLQD VLPKYILDFS
361 LFAYPLPNVT KEACQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHST14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- placenta: 25 nTPM
- ovary: 24 nTPM
- cervix: 22 nTPM
- endometrium: 21 nTPM
- blood vessel: 21 nTPM
- fallopian tube: 17 nTPM
Single-cell type
- cytotrophoblasts: 55 nCPM
- migrating cytotrophoblasts: 44 nCPM
- extravillous trophoblasts: 36 nCPM
- decidual stromal cells: 17 nCPM
- fibroblasts: 14 nCPM
- granulosa cells: 14 nCPM
Immune cell
- basophil: 7.5 nTPM
- NK-cell: 3.4 nTPM
- gdT-cell: 2.3 nTPM
- eosinophil: 2.2 nTPM
- myeloid DC: 2 nTPM
- memory CD8 T-cell: 1.9 nTPM
Brain region
- medulla oblongata: 8.7 nTPM
- basal ganglia: 7.6 nTPM
- spinal cord: 7.6 nTPM
- choroid plexus: 7.2 nTPM
- white matter: 7 nTPM
- midbrain: 6.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHST14.
Disease | AllUniProt
Conditions CHST14 is implicated in, by any mechanism.
- Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) MIM:601776
Disease | GeneticClinVar
37 pathogenic / likely-pathogenic of 431 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ehlers-Danlos syndrome, musculocontractural type
- Ehlers-Danlos syndrome, musculocontractural type 1
- Cardiovascular phenotype
- CHST14-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.45
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate biosynthetic process
- dermatan sulfate proteoglycan biosynthetic process
- dermatan sulfate proteoglycan metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHST14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHST14 as an antibody target. Whether an autoantibody or antibody against CHST14 could matter depends on whether native CHST14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHST14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHST14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...